Improving communication for epilepsy clinic visits
Drug-Resistant Epilepsy (DRE) Goals for Epilepsy Clinical Visits mHealth Epilepsy Visit Planner Trial
This study is testing a tablet tool called the 'Epilepsy Visit Planner' to see if it helps people with drug-resistant epilepsy communicate better with their doctors and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 152 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT05928598 on ClinicalTrials.gov |
What this trial studies
This project aims to evaluate the effectiveness of a tablet-based communication tool called the 'Epilepsy Visit Planner' in enhancing patient-provider interactions for individuals with drug-resistant epilepsy. The trial will compare outcomes between patients who use the planner and those who do not, focusing on improvements in communication and quality of life. Additionally, the study will assess the feasibility and acceptability of the tool for potential future larger-scale studies.
Who should consider this trial
Good fit: Ideal candidates are adults with drug-resistant epilepsy receiving care at the University of Michigan epilepsy clinics.
Not a fit: Patients under 18, non-English speakers, or those with cognitive impairments that hinder questionnaire completion may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly enhance communication between patients and providers, leading to better management of epilepsy.
How similar studies have performed: While the specific approach of using a tablet-based communication tool is novel, similar studies have shown that improved communication can lead to better patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria - Patient Participants: * Adults with drug-resistant epilepsy * Participants receiving care through the Epilepsy clinics at the University of Michigan Exclusion Criteria - Patient Participants: * \<18 years old * Non-English speaking * Do not clearly have drug-resistant epilepsy * Moderate-to-severe cognitive impairment that precludes study questionnaire completion Inclusion Criteria - Provider Participants: -University of Michigan epilepsy providers Exclusion Criteria - Provider Participants: -Not University of Michigan epilepsy providers
Where this trial is running
Ann Arbor, Michigan
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
Study contacts
- Principal investigator: Chloe Hill, MD — University of Michigan
- Study coordinator: Queen Bolden
- Email: qmbolden@umich.edu
- Phone: 734-615-5495
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.